A61K 9/2004
Excipients
Official title: {Excipients; Inactive ingredients}
A61K9/2004 (Excipients) appears on 8,600 US grants and 15,248 published applications in this corpus.
Search patents in A61K- Granted patents
- 8,600
- Published applications
- 15,248
- Assignees
- 4,256
- Inventors
- 22,584
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 31 | 0 |
| 1977 | 16 | 0 |
| 1978 | 23 | 0 |
| 1979 | 15 | 0 |
| 1980 | 17 | 0 |
| 1981 | 27 | 0 |
| 1982 | 30 | 0 |
| 1983 | 26 | 0 |
| 1984 | 33 | 0 |
| 1985 | 33 | 0 |
| 1986 | 38 | 0 |
| 1987 | 49 | 0 |
| 1988 | 53 | 0 |
| 1989 | 82 | 0 |
| 1990 | 64 | 0 |
| 1991 | 75 | 0 |
| 1992 | 62 | 0 |
| 1993 | 59 | 0 |
| 1994 | 50 | 0 |
| 1995 | 68 | 0 |
| 1996 | 85 | 0 |
| 1997 | 129 | 0 |
| 1998 | 112 | 0 |
| 1999 | 143 | 0 |
| 2000 | 140 | 0 |
| 2001 | 199 | 70 |
| 2002 | 151 | 230 |
| 2003 | 174 | 411 |
| 2004 | 118 | 424 |
| 2005 | 107 | 453 |
| 2006 | 104 | 420 |
| 2007 | 76 | 467 |
| 2008 | 77 | 496 |
| 2009 | 75 | 459 |
| 2010 | 154 | 575 |
| 2011 | 168 | 556 |
| 2012 | 224 | 540 |
| 2013 | 328 | 646 |
| 2014 | 420 | 700 |
| 2015 | 409 | 757 |
| 2016 | 412 | 767 |
| 2017 | 500 | 779 |
| 2018 | 407 | 695 |
| 2019 | 427 | 747 |
| 2020 | 451 | 805 |
| 2021 | 430 | 766 |
| 2022 | 403 | 787 |
| 2023 | 341 | 735 |
| 2024 | 391 | 693 |
| 2025 | 366 | 702 |
| 2026 | 228 | 568 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Tableting of specific polymer stabilizers6 Oct 2026US 12,751,926 B2BASF SE
- Dosage forms for TYK2 inhibitors6 Oct 2026US 12,751,948 B2Bristol-Myers Squibb Company
- Formulation for oral administration, comprising triazine derivative6 Oct 2026US 12,751,955 B2Shionogi & Co., Ltd.
- Combination drug for the control and management of type 2 diabetes mellitus6 Oct 2026US 12,751,958 B2Laboratorios Silanes S.A. de C.V.
- Oral formulations and uses thereof29 Sep 2026US 12,746,229 B2Inventisbio Co., Ltd.
- Drug-polymer amorphous solid dispersions using linear polyacrylic acid polymers8 Oct 2026US 2026/0306410 A1Lubrizol Advanced Materials, Inc.
- Pharmaceutical oral dosage form of q2038 Oct 2026US 2026/0306411 A1Qurient Co., Ltd.
- Triptolide formulations8 Oct 2026US 2026/0306412 A1Minneamrita Therapeutics LLC
- Colonic purgative tablet and colonic purgative comprising same8 Oct 2026US 2026/0306413 A1Pharmbio Korea Co., Ltd.
- Compounds and combinations thereof for treating neurological and psychiatric conditions8 Oct 2026US 2026/0306426 A1Antecip Bioventures II LLC
Most cited
By later US patents
- Temperature-controlled active agent dispenser1,474US 4,830,855 ALandec Labs, Inc. · 1989
- Method of treating androgen independent prostate cancer1,091US 9,040,574 B2Natrogen Therapeutics International, Inc. · 2015
- Method of moving a delivery member of a dispensing device for administration of oral transmucosal dosage forms654US 8,499,966 B2AcelRx Pharmaceuticals, Inc. · 2013
- Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels548US 6,605,294 B2Incept, LLC · 2003
- Controlled release oxycodone compositions466US 5,508,042 AEuro-Celtigue, S.A. · 1996